Odd Biotech Action Is Creating Opportunities for Deal Hunters
Let’s see how the best trades are often found by looking past the indexes and digging into what is going on inside a sector.
Let’s see how the best trades are often found by looking past the indexes and digging into what is going on inside a sector.
The S&P notched its first record close since August on a continued broadening as Treasury yields remained subdued. The Nasdaq added a second straight record, but small-caps gave up an early gain.
This split action has been going on for so long now that everyone is aware of it.
As biotech is getting hit and we’re seeing ETF-driven selling, I smell opportunity for sharp traders.
Payrolls missed every estimate, raising bets for an October FOMC hold, and the Nasdaq-100 powered to a record high. But Treasury yields reversed an early drop.
A cooler-than-expected core PCE lifted stocks early, but a rebound in yields and a sharp final-hour selloff left the Nasdaq as the lone gainer on the day and month.
Rumors of a potential deal to open the Strait of Hormuz lifted stocks out of the red, but another rise in yields and oil prices kept them under pressure.
A sixth day of gains for semiconductors drives the Nasdaq-100 to its first record since June while a fifth day of losses for crude boosted small caps
Tech’s continued rebound along with falling oil prices and Treasury yields drove a powerful rally to start the week.
Conditions for a difficult September are in place, but it will also create new opportunities.